Cargando…
Efficacy and safety of short-term use of a pelubiprofen CR and aceclofenac in patients with symptomatic knee osteoarthritis: A double-blinded, randomized, multicenter, active drug comparative, parallel-group, phase IV, non-inferiority clinical trial
INTRODUCTION: At present, information about clinical efficacy and adverse events of controlled release (CR) form of pelubiprofen, a prodrug of 2-arylopropionic acid with relatively selective effects on cyclooxygenase-2 activity, remains scarce. In this study, we sought to determine non-inferiority o...
Autores principales: | Shin, Joung Youp, Chang, Moon Jong, Kim, Myung Ku, Kang, Seung-Baik, Kim, Kang-Il, Park, Hee Gon, Lee, Sahnghoon, Kim, Sung-Hwan, Han, Seung-Beom, Lee, Han Jun, Moon, Young-Wan, Yoo, Jae-Doo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523996/ https://www.ncbi.nlm.nih.gov/pubmed/32991606 http://dx.doi.org/10.1371/journal.pone.0238024 |
Ejemplares similares
-
Pharmacokinetic and Pharmacodynamic Characteristics of Pelubiprofen Tromethamine vs. Pelubiprofen in Healthy Subjects
por: Son, Yu-Jeong, et al.
Publicado: (2023) -
Efficacy and Safety of Aceclofenac Controlled Release in Patients with Knee Osteoarthritis: A 4-week, Multicenter, Randomized, Comparative Clinical Study
por: Moon, Young-Wan, et al.
Publicado: (2014) -
Development of Pelubiprofen Tromethamine with Improved Gastrointestinal Safety and Absorption
por: Park, Ji Yeon, et al.
Publicado: (2021) -
Eccrine Squamous Syringometaplasia Associated with Pelubiprofen Therapy
por: Huh, Joon Won, et al.
Publicado: (2017) -
Comparison of the efficacy and safety profiles of a pelubiprofen versus celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, phase III, non-inferiority clinical trial
por: Choi, In Ah, et al.
Publicado: (2014)